United Therapeutics (UTHR) Tops Q1 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $584.93 -1.33%
Revenue Growth %: -1.8%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
OMID, SICP, SCKT, More
Revenue Growth %: -1.8%
Financial Fact:
Total other (expense) income, net: 500K
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $1.77, $0.12 better than the analyst estimate of $1.65. Revenue for the quarter came in at $289.4 million versus the consensus estimate of $300.14 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- HBT Financial (HBT) PT Raised to $43 at Keefe, Bruyette & Woods
- First Financial (THFF) Tops Q3 EPS by 28c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
